SEC Form D · filed November 3, 2021
Antiva Biosciences, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (29)
Sarah Walter · BRISBANE, CAExecGail Maderis · BRISBANE, CAExec · DirectorJenny Yip · BRISBANE, CADirectorWende Hutton · BRISBANE, CADirectorClifford Samuel · BRISBANE, CADirectorRaju Gadiraju · BRISBANE, CAExecOranee Daniels · BRISBANE, CAExecVinzenz Ploerer · Palm Beach Gardens, FLDirectorJefferson W. Kirby · Morristown, NJExecKenneth J. Burns · NEW YORK, NYDirectorJ. W. Kirby, Jr · Morristown, NJExecJohn Cozzi · NEW YORK, NYDirectorSame Broadfield Capital, LLC · Morristown, NJExecSame Broadfield Capital Management, LLC · Morristown, NJDirectorDimitre Kirilov · Bensenville, ILExec · DirectorSteven James · San Diego, CADirectorBenjamin Rovinski · Chapel Hill, NCDirectorDavid Kabakoff · La Jolla, CADirectorBrad R. Banks · CAMBRIDGE, MAExec · DirectorCamilo R. Cepeda · CAMBRIDGE, MADirectorWilliam C. Collin · Richmond, VAExecCharles C. Wills · Richmond, VAExecJohn C. Eckstein · Richmond, VAExecJames C. Rose, Jr · Richmond, VADirectorJason Lieber · Woodmere, NYDirectorSteven James · San Diego, CADirectorBenjamin Rovinski · Chapel Hill, NCDirectorVinzenz Ploerer · Rockville, MDDirectorDavid Kabakoff · San Diego, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗